Dr Britt Nobus
ActiveDr Britt Nobus has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €88k and a net result of €61k. Equity is growing by ~19.8% per year across the filed fiscal years. Its solvency ranks better than 39% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
88
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency81▼-19
Growth42▼-10
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity ample (current ratio 2.15 against 10.4 in 2023; short-term debt: 44% and cash: 74.4% of total assets), and 44% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
61 d late
2022
32 d late
2021
5 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€88k▼ 52.8%
2023 · €187k
2021: €88k
2022: €127k
2023: €187k
2021 → 2024
Total assets
€158k▼ 23.3%
2023 · €206k
2021: €126k
2022: €148k
2023: €206k
2021 → 2024
Net result
€61k▲ 1.1%
2023 · €60k
2021: €85k
2022: €38k
2023: €60k
2021 → 2024
Working capital
€80k▼ 54.3%
2023 · €175k
2021: €87k
2022: €121k
2023: €175k
2021 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2021202220232024Trend
Equity€88k-€127k▲ 43.5%€187k▲ 47.6%€88k▼ 52.8%
Operating result€119k-€49k▼ 58.7%€76k▲ 55.4%€77k▲ 0.9%
Net result€85k-€38k▼ 54.8%€60k▲ 57.1%€61k▲ 1.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed two years in a row; 2024 is 1% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €158k
Fixed assets
€8k▼ 28.9%
Current assets
€149k▼ 23.0%
Equity and liabilities €158k
Equity
€88k▼ 52.8%
Debt
€69k▲ 272%
The debt ratio rises from 9.1% to 44.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€80k▲
2023 · €78k
Cash flow
€64k▲
2023 · €62k
Solvency
56.0%▼
2023 · 90.9%
Current ratio
2.15▼
2023 · 10.40
Quick ratio
2.15▼
2023 · 10.40
Debt / equity
0.79▲
2023 · 0.10
ROE
69.0%▲
2023 · 32.2%
ROA
38.6%▲
2023 · 29.3%
Interest coverage
226.71▲
2023 · 206.62
Debt
€69k▲
2023 · €19k
Debt ≤ 1 year
€69k▲
2023 · €19k
Income taxes
€16k▲
2023 · €16k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€206k€158k▼
Fixed assets21/28€12k€8k▼
Tangible fixed assets22/27€10k€7k▼
Plant, machinery and equipment23€5k€3k▼
Furniture and vehicles24€6k€4k▼
Financial fixed assets28€1k€1k=
Current assets29/58€194k€149k▼
Amounts receivable within one year40/41€43k€32k▼
Trade receivables40€10k€0▼
Other amounts receivable41€33k€32k▼
Cash at bank and in hand54/58€150k€117k▼
Deferred charges and accrued income490/1€375€546▲
Equity and liabilities
Total equity and liabilities10/49€206k€158k▼
Equity10/15€187k€88k▼
Contributions10/11€4k€4k=
Reserves13€85k€85k=
Distributable reserves133€85k€85k=
Profit (loss) carried forward14€99k€0▼
Amounts payable17/49€19k€69k▲
Amounts payable within one year42/48€19k€69k▲
Trade debts44€772€2k▲
Suppliers440/4€772€2k▲
Taxes, remuneration and social security45€17k€3k▼
Taxes450/3€17k€3k▼
Other amounts payable47/48€1k€64k▲
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€3k▲
Other operating charges640/8€732€1k▲
Gross operating margin9900€79k€81k▲
Operating profit (loss)9901€76k€77k▲
Financial income75/76B€165€616▲
Recurring financial income75€165€616▲
Financial charges65/66B€379€354▼
Recurring financial charges65€379€354▼
Profit (loss) for the period before taxes9903€76k€77k▲
Income taxes67/77€16k€16k▲
Profit (loss) for the period9904€60k€61k▲
Profit (loss) for the period to be appropriated9905€60k€61k▲
Appropriation of the result
Profit (loss) to be appropriated9906€99k€159k▲
Profit (loss) brought forward from the previous period14P€38k€99k▲
Profit to be distributed694/7-€159k
Return on contributions (dividend)694-€159k
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
30-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 61 days late
2023
31-12
Financial
Equity above €150kEq €187k ▲47.6%
3 profitable years in a row build equity to €187k.
01-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 32 days late
2022
31-12
Financial
Weakest financial yearnet €38k ▼54.8%
Net result drops to €38k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 6.74
Current ratio from 3.31 to 6.74; short-term debt falls from €38k to €21k.
31-12
Financial
Equity above €100kEq €127k ▲43.5%
2 profitable years in a row build equity to €127k.
05-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 5 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hove · 2 establishment units since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Verbindingsstraat 322540 HoveGround area
2,523 m²
Building footprint
126 m²
Volume, LiDAR
588 m³
2 parcels, Flanders · tallest building 8.6 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
Dr Britt Nobus
since 20212.315.318.635
Koningin Astridlaan 113, 2550 Kontich
since 20262.392.384.838
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11602C0027/00N020 | Flanders | 1,621 m² | - | - |
| 11021B0027/00X002 | Flanders | 902 m² | 1 · 126 m² | 8.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dokter Lies Knippenberg
BE 0752.515.211
Maaseik · Eq €88k
Dr. Sam Delvaux
BE 0773.946.667
Leuven · Eq €88k
Dr. Cis Nicasy
BE 0737.569.390
Geel · Eq €88k
Dr. Pauline Van den Bossche
BE 1014.597.234
Waasmunster · Eq €88k
VanCor Huisartsen
BE 0741.417.619
Heusden-Zolder · Eq €88k
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,187 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded23-03-2021
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.